Eli Casdin's Net Worth
$374 Million
Who is Eli Casdin?
Eli Casdin has an estimated net worth of $374 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., BIOLIFE SOLUTIONS INC, MAXCYTE, INC., Generation Bio Co., Tenaya Therapeutics, Inc., STANDARD BIOTOOLS INC., SomaLogic, Inc., EXACT SCIENCES CORP, Absci Corp, Century Therapeutics, Inc., GeneDx Holdings Corp., and EQRx, Inc..
SEC CIK
Eli Casdin's CIK is 0001534264
Past Insider Trading and Trends
2021 was Eli Casdin's most active year for acquiring shares with 37 total transactions. Eli Casdin's most active month to acquire stocks was the month of June. 2021 was Eli Casdin's most active year for disposing of shares, totalling 15 transactions. Eli Casdin's most active month to dispose stocks was the month of June. 2021 saw Eli Casdin paying a total of $201,150,000.00 for 188,940,443 shares, this is the most they've acquired in one year. In 2022 Eli Casdin cashed out on 3,984,170 shares for a total of $18,437,940.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SomaLogic, Inc. (SLGC) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -19.41M |
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +100.00% | 3.43K |
—
|
—
| 6.86K |
Mar 17
| |||
Form 4
| +2.17% | 215.19K |
—
|
—
| 10.13M |
Sep 29
| |||
Form 4
|
∞
| 3.43K |
—
|
—
| 3.43K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
| +81.69% | 19.19M |
$10.00 | $25,000,000.00 | 42.68M |
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GeneDx Holdings Corp. (WGS) Snapshot price: $3.72
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
| +330.20% | 5.83K |
—
|
—
| 7.59K |
Jun 20
| |||
Form 4
| +4.39% | 130K |
$21.21 | $2,757,117.00 | 3.09M |
Jun 3 - Jun 4
| |||
Form 4
| +1.37% | 40K |
$21.07 | $842,604.00 | 2.96M |
May 29
| |||
Form 4
| +6.17% | 170K |
$20.15 | $3,424,989.02 | 2.92M |
May 23 - May 28
| |||
Form 4
| +1.85% | 50K |
$23.31 | $1,165,295.00 | 2.75M |
May 13
| |||
Form 4
| +1.54% | 40.9K |
$8.74 | $357,652.30 | 2.7M |
Mar 4 - Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
| +354.11% | 45.45K |
—
|
—
| 58.29K |
May 2
| |||
Form 4
| +521.46% | 85.71M |
$0.35 | $29,999,999.75 | 102.15M |
Jan 31
| |||
Form 4
|
∞
| 12.84K |
—
|
—
| 12.84K |
Apr 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +228.75% | 11.44M |
$4.00 | $45,750,000.00 | 16.44M |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
∞
| 15.99M |
—
|
—
| 15.99M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EQRx, Inc. (EQRX) No price found
Officer (CEO)
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -48.19M |
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4/A
|
∞
| 48.19M |
$10.00 |
—
| 48.19M |
Dec 17
| |||
Form 4
| +556.47% | 48.19M |
$10.00 | $50,000,000.00 | 56.85M |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 771.41K |
$15.00 |
—
| 771.41K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 604.28K |
$15.84 |
—
| 604.28K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||